Splenic gene delivery system using self-assembling nano-complex with phosphatidylserine analog

Biological & Pharmaceutical Bulletin
Tomoaki KurosakiHitoshi Sasaki

Abstract

The recognition of phosphatidylserine on the erythrocyte membrane mediates erythrophagocytosis by resident spleen macrophages. The application of phosphatidylserine to a gene vector may be a novel approach for splenic drug delivery. Therefore, we chose 1,2-dioleoyl-sn-glycero-3-phospho-L-serin (DOPS) as an analogue of phosphatidylserine for splenic gene delivery of plasmid DNA (pDNA). In the present study, we successfully prepared a stable pDNA ternary complex using DOPS and polyethyleneimine (PEI) and evaluated its efficacy and safety. The pDNA/PEI complex had a positive charge and showed high transgene efficacy, although it caused cytotoxicity and agglutination. The addition of DOPS changed the ζ-potential of the pDNA/PEI complex to negative. It is known that anionic complexes are not taken up well by cells. Surprisingly, however, the pDNA/PEI/DOPS complex showed relatively high transgene efficacy in vitro. Fluorescence microscope observation revealed that the pDNA/PEI/DOPS complex internalized the cells while maintaining the complex formation. The injection of the pDNA/PEI complex killed most mice within 24 h at high doses, although all mice in the pDNA/PEI/DOPS complex group survived. The ternary complex with DOPS showed ma...Continue Reading

References

Jul 30, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·W T GodbeyA G Mikos
Apr 25, 2001·The Journal of Gene Medicine·A KichlerO Danos
Jun 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Antoine KichlerBenoît Frisch
Oct 19, 2002·Nutritional Neuroscience·B L JorissenW J Riedel
Feb 11, 2003·Journal of Lipid Research·David L Daleke
Nov 20, 2003·Trends in Cell Biology·Cynthia Grimsley, Kodi S Ravichandran
Feb 14, 2004·Cellular Immunology·Munehisa Takahashi, Yoshiro Kobayashi
Jul 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hongtao LvJie Yan
Oct 28, 2006·Toxicologic Pathology·Mark F Cesta
Dec 7, 2007·Journal of the International Society of Sports Nutrition·Ralf JägerHolger Herwegen
Dec 9, 2008·Blood Reviews·Anna L PozoKristian M Bowles
Feb 3, 2009·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Tomoaki KurosakiHitoshi Sasaki
Dec 19, 2009·Cell Death and Differentiation·I K H PoonC R Parish
Mar 10, 2010·Cell·Shigekazu NagataKohki Kawane
Apr 13, 2010·Biochimica Et Biophysica Acta·A Christy Hunter, S Moein Moghimi
Sep 2, 2010·The Journal of Experimental Medicine·Kodi S Ravichandran
Nov 26, 2010·Journal of Clinical Biochemistry and Nutrition·Akito Kato-KataokaTakashi Miyamori
May 12, 2011·Molecular Pharmaceutics·Tomoaki KurosakiTakashi Kitahara
Oct 10, 2013·Macromolecular Bioscience·Abdulaziz AlmalikNicola Tirelli
Nov 6, 2013·Biological & Pharmaceutical Bulletin·Tomoaki KurosakiHitoshi Sasaki

❮ Previous
Next ❯

Citations

Apr 3, 2020·Biological & Pharmaceutical Bulletin·Ikramy A KhalilHideyoshi Harashima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Yukinobu KodamaHitoshi Sasaki
© 2022 Meta ULC. All rights reserved